Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, United States

Publications

• Case Reports   
  Midostaurin combined with CPX-351 (Vyxeos) appears safe for induction in FLT3 mutated acute myeloid leukemia
  Author(s): Ramzi Abboud, Kristan M. Augustin, Matthew J. Walter, Camille N. Abboud and John S. Welch**

  • Abstract
  • Full-Text
  • PDF